vTv Therapeutics (VTVT) Long-Term Debt Issuances (2014 - 2017)

vTv Therapeutics has disclosed Long-Term Debt Issuances across 3 years of filings, most recently posting $7.5 million for Q1 2017.

• Long-Term Debt Issuances for Q1 2017 came in at $7.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $7.5 million (changed 0.0% YoY), and the FY2025 annual result was $392000.0, changed N/A from the prior year.
• Long-Term Debt Issuances came in at $7.5 million for Q1 2017 at vTv Therapeutics, up from $13000.0 in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $10.5 million in Q2 2015 to a low of $13000.0 in Q3 2015.
• The 3-year median for Long-Term Debt Issuances is $8.2 million (2015), against an average of $6.9 million.
• Peak annual rise in Long-Term Debt Issuances reached 99.74% in 2015, while the deepest fall reached 99.74% in 2015.
• vTv Therapeutics' Long-Term Debt Issuances stood at $9.7 million in 2014, then sank by 99.87% to $13000.0 in 2015, then surged by 57592.31% to $7.5 million in 2017.
• The last three Long-Term Debt Issuances figures came in at $7.5 million (Q1 2017), $13000.0 (Q3 2015), and $10.5 million (Q2 2015), per Business Quant data.